Ledger.Open graph →
SEC Form D · filed October 30, 2018

Emergent BioSolutions Inc

Offering
$47.9M
Sold
$47.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

George J. Joulwan · Gaithersburg, MDDirectorRobert G. Kramer · Gaithersburg, MDExecRonald B. Richard · Gaithersburg, MDDirectorKatherine R. Strei · Gaithersburg, MDExecFuad El-Hibri · Gaithersburg, MDExec · DirectorAdam R. Havey · Gaithersburg, MDExecSue J. Bailey · Gaithersburg, MDDirectorDaniel J. Abdun-Nabi · Gaithersburg, MDExec · DirectorLouis W. Sullivan · Gaithersburg, MDDirectorZsolt J. Harsanyi · Gaithersburg, MDDirectorKathryn C. Zoon · Gaithersburg, MDDirectorJerome M. Hauer · Gaithersburg, MDDirectorRichard S. Lindahl · Gaithersburg, MDExecAtul R. Saran · Gaithersburg, MDExecGeorge J. Joulwan · Gaithersburg, MDDirectorRobert G. Kramer · Gaithersburg, MDExecRonald B. Richard · Gaithersburg, MDDirectorKatherine R. Strei · Gaithersburg, MDExecFuad El-Hibri · Gaithersburg, MDExec · DirectorAdam R. Havey · Gaithersburg, MDExecSue J. Bailey · Gaithersburg, MDDirectorDaniel J. Abdun-Nabi · Gaithersburg, MDExec · DirectorLouis W. Sullivan · Gaithersburg, MDDirectorZsolt J. Harsanyi · Gaithersburg, MDDirectorKathryn C. Zoon · Gaithersburg, MDDirectorJerome M. Hauer · Gaithersburg, MDDirectorRichard S. Lindahl · Gaithersburg, MDExecAtul R. Saran · Gaithersburg, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗